Susquehanna Fundamental Investments’s Aethlon Medical AEMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$19K Sell
16
-1
-6% -$1.19K ﹤0.01% 1513
2021
Q4
$25K Buy
+17
New +$38.7K ﹤0.01% 1392

Other funds holding AEMD

Susquehanna Fundamental Investments's AEMD Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Aethlon Medical (AEMD) stake by 5.9% in Q1 2022, selling an estimated $1.19K and leaving 16 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1513.

Susquehanna Fundamental Investments first reported a position in AEMD in Q4 2021 and has held it in 2 quarters since. The position peaked at $25K in Q4 2021. 22 funds tracked by Wall St. Rank hold AEMD as of Q1 2022.

  • Susquehanna Fundamental Investments held 16 shares of Aethlon Medical worth $19K as of Q1 2022.
  • Susquehanna Fundamental Investments sold 1 Aethlon Medical share in Q1 2022, an estimated $1.19K.
  • Aethlon Medical made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1513 holding.
  • Susquehanna Fundamental Investments first reported a position in Aethlon Medical in Q4 2021 and has held it in 2 quarters since.
  • Susquehanna Fundamental Investments's Aethlon Medical position peaked at $25K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.